Irvine, Calif., Dec. 2, 2015 -- A University of California, Irvine pharmacology researcher has helped create a class of inhibitory compounds that can strongly enhance the effect of anti-tumor drugs for melanoma.
In doing so, Daniele Piomelli, the Louise Turner Arnold Chair in the Neurosciences at UCI, and scientists at the Italian Institute of Technology identified how an enzyme called acid ceramidase can accelerate tumor growth in this deadly form of skin cancer.